ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NNVC NanoViricides Inc

2.05
-0.53 (-20.54%)
Last Updated: 09:45:44
Delayed by 15 minutes

Period:

Draw Mode:

Volume 277,063
Bid Price
Ask Price
News -
Day High 2.579

Low
1.00

52 Week Range

High
3.59

Day Low 2.01
Share Name Share Symbol Market Stock Type
NanoViricides Inc NNVC AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
-0.53 -20.54% 2.05 09:45:44
Open Price Low Price High Price Close Price Previous Close
2.55 2.01 2.579 2.58
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
966 277,063 US$ 2.20 US$ 609,306 - 1.00 - 3.59
Last Trade Type Quantity Price Currency
09:45:44 200 US$ 2.05 USD

NanoViricides Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
29.45M 11.78M - 0 -8.59M -0.73 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

NanoViricides News

Date Time Source News Article
5/02/202409:07InvestorsHub NewsWireNanoViricides Reports that the Phase I NV-387 Clinical Trial..
2/16/202415:53Edgar (US Regulatory)Form 8-K - Current report
2/14/202415:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
1/19/202415:44Edgar (US Regulatory)Form 8-K - Current report
12/04/202315:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statements
10/13/202315:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
9/28/202315:44Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form..
9/01/202315:46Edgar (US Regulatory)Form 8-K - Current report
7/06/202310:16InvestorsHub NewsWireClinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NNVC Message Board. Create One! See More Posts on NNVC Message Board See More Message Board Posts

Historical NNVC Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.653.591.882.85604,283-0.60-22.64%
1 Month2.223.591.882.60370,744-0.17-7.66%
3 Months1.163.591.02972.22219,9580.8976.72%
6 Months1.163.591.00012.05120,8480.8976.72%
1 Year1.083.591.001.8294,5000.9789.81%
3 Years4.527.861.004.72350,731-2.47-54.65%
5 Years0.2519.800.160457.10689,4871.80720.00%

NanoViricides Description

Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy.

Your Recent History

Delayed Upgrade Clock